2023-09-13 15:25:18
Title: The Evolution of Multiple Sclerosis Treatment: More Choices, More Complications
Subtitle: Join AMSEL Expert Chat for Insights on Multiple Sclerosis Therapy
Incredible, but it was actually less than 30 years ago that the first immune modulating agent against MS was approved in Germany: in November 1995, it was the interferon called “Betaferon.”
A lot has happened since then. There are now around 20 preparations on the market approved for multiple sclerosis. And all interferons belong to effectiveness category 1 – out of a total of three. This means that there are now significantly more effective medications against MS.
However, each active ingredient has its own mode of action, can cause different serious side effects, and is only approved for certain courses. In addition, there is the “spoiled for choice” between oral agents, injections, and infusions, those that you have to think about twice a day, and others that are only used every six months, active ingredients that do not endanger pregnancy, those that are taken while you are taking them you should not become pregnant, and those for whom the desire to have children should definitely be finalized beforehand.
Not to mention the contraindications such as certain heart or liver diseases. And active ingredients that can make it easy or difficult to switch later. And the personal attitude, which can range from one; starting out gently and, if necessary, switching to stronger remedies later or using the opposite strategy of “hit hard and early” – some neurologists see this strategy as having great advantages for long-term brain health.
However, the choice of therapy always remains a shared one between the patient and the doctor. In order to be able to make wise decisions, it helps to be informed. A conversation with a neurologist is not always enough to clarify everything. Or the most important questions only arise after the consultation hour.
This is exactly where the AMSEL expert chat helps. Prof. Ingo Kleiter looks forward to your questions next Tuesday evening, September 19th, 7-8:30 p.m. Kleiter is the medical director and managing director of the Marianne Strauss Clinic in Berg and is very familiar with multiple sclerosis and its therapy.
Join the AMSEL expert chat to gain insights into multiple sclerosis treatment and make informed decisions about your health.]
#Treating #moderate #highly #active #AMSEL #aktuell #Multiple #Sclerosis #News